ArticleMDM policy & practice

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway.

Lars Asphaug et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.